HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preliminary Interpretations of Epigenetic Profiling of Cord Blood in Preeclampsia.

Abstract
Preeclampsia (PE) is characterized by new-onset hypertension after 20 weeks of pregnancy and results in high maternal and fetal mortality worldwide. It has been reported that PE is associated with abnormalities in the umbilical cord and cord blood. However, previous studies were focused primarily on the transcriptomics level, while the underlying gene regulatory landscapes are still unclear. Thus, we performed the Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq) using the umbilical cord blood samples collected from a patient with superimposed PE and three healthy donors to uncover the chromatin accessibility changes attributed to PE. We have identified genes associated with immunomodulation and hypoxia response that have higher chromatin accessibility close to their transcription start sites. Motif analysis indicated that the GATA family transcription factor binding was enriched in PE and may play an essential regulatory role in the disease progression. Overall, our findings provide an overview of gene regulatory programs and the corresponding downstream pathways associated with PE that may influence the placenta function and fetal growth.
AuthorsJunrui Ma, Zhongqun Zhan, Ning Li, Yanli Huang, Yan Li, Lu Liu, Qi Shen, Qiao Chu, Xiaonan Wang, Benqing Wu, Hui Zhang
JournalGenes (Genes (Basel)) Vol. 13 Issue 5 (05 16 2022) ISSN: 2073-4425 [Electronic] Switzerland
PMID35627272 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chromatin
Topics
  • Chromatin
  • Chromatin Immunoprecipitation Sequencing
  • Epigenesis, Genetic
  • Female
  • Fetal Blood
  • Humans
  • Pre-Eclampsia (genetics)
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: